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Disulﬁde bonds are important in the folding of secreted proteins.
The formation of disulﬁdes can conceptually be divided into two steps,
the oxidation of cysteine residues to form disulﬁdes, and the
isomerization of incorrect disulﬁdes to the correct disulﬁde bonded
pattern. For proteins with more than two cysteines, the number of
possible incorrect disulﬁde bonding patterns increases very rapidly
with cysteine number, whereas the number of correct disulﬁde
bonding patterns remains constant at one. Thus, disulﬁde isomerases
play vital roles in the folding of proteins, particularly for proteins with
multiple cysteine residues. In the early 1960s, Anﬁnsen and colleagues
hypothesized the need for a protein to catalyze disulﬁde isomerization
and discovered an endoplasmic reticulum protein, later called protein
disulﬁde isomerase (PDI), involved in this process [1,2]. More recently,
prokaryotes were shown to contain a related protein called DsbC that
is involved in disulﬁde isomerization. Both PDI and DsbC act by thiol-
disulﬁde exchange with secreted proteins, and function to catalyze
protein folding [3]. This review focuses on disulﬁde isomerization in
prokaryotes, particularly in E. coli since it is the best studied. The
process of disulﬁde oxidation is only described as it is relevant to
disulﬁde isomerization.
2. DsbA is the main oxidase in the periplasm of E. coli
Oxidative protein folding is catalyzed by the Dsb proteins present
in the periplasmic space of prokaryotes [4]. DsbA serves as the directl).
ibitor; PDI, protein disulﬁde
l rights reserved.donor of disulﬁdes to secreted proteins, whereas DsbC serves as the
isomerase of incorrect disulﬁde bonds. Strains that are mutant in the
dsbA gene show a severe defect in disulﬁde bond formation.
DsbA acts by donating its disulﬁde to secreted proteins, thereby
catalyzing their oxidative folding. DsbA oxidizes reduced polypeptides
extremely rapidly, with rate constants of about 107 M−1s−1 at pH 7.5.
This is about a million times faster than normal values for disulﬁde
exchange reactions between proteins [43]. DsbA is also one of the
most oxidizing thiol-disulﬁde oxidoreductases known, with a redox
potential of −121 mV [5]. Given the very oxidizing redox potential of
DsbA, it is not surprising that it can form incorrect disulﬁdes. One
reasonable model of DsbA function is that it oxidizes adjacent
cysteines (consecutive disulﬁdes) as they are secreted into the
periplasmic space. Proteins secreted by the commonly used “sec”
secretion apparatus are secreted from the N- to C-terminus. Thus, one
simple model would be that DsbA may only be able to form correct
disulﬁdes if they all form between cysteines that are adjacent in the
sequence [6]. Any other disulﬁde conﬁguration (non-consecutive
disulﬁde) would then require the disulﬁde isomerase DsbC. Thus, the
paradigm that has been guiding the disulﬁde bond formation ﬁeld for
some time is that DsbA functions entirely as an oxidizing thiol-
disulﬁde oxidoreductase, whereas DsbC functions as a disulﬁde
isomerase. This is in contrast to the situation in the eukaryotic ﬁeld,
inwhich a single protein disulﬁde isomerase is thought to play roles in
both isomerization and oxidation.
3. DsbB is a membrane protein that reoxidizes DsbA
The oxidation of a substrate protein by DsbA reduces DsbA. In
order to be catalytic, DsbA must be reoxidized; this reoxidation is
performed by the membrane protein DsbB. DsbB generates protein
disulﬁdes de novo, via the reduction of quinones [8,9]. DsbB is thus the
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have mutations in the dsbB gene showed accumulation of reduced
DsbA in the periplasm and exhibited the same pleiotropic phenotypes
as dsbAmutants. DsbB is reoxidized by components of the respiratory
chain, which accept electrons from DsbB. Under aerobic conditions,
DsbB transfers the electrons to oxidized ubiquinone. The reduced
ubiquinone then becomes reoxidized by the terminal cytochrome
oxidases, which ﬁnally transfer the electrons onto molecular oxygen
[8,10]. Under anaerobic conditions, DsbB transfers electrons to
menaquinone, which then passes them to the ﬁnal electron acceptors
fumarate or nitrate [8]. DsbB has four membrane-spanning segments
and two pairs of essential cysteines, Cys41-Cys44, and Cys104-Cys130.
One of each pair is located in each of the two periplasmic domains
[11]. These cysteines are involved in a disulﬁde cascade reaction
within DsbB that ends up transferring a disulﬁde to DsbA [9].
4. DsbC, a periplasmic isomerase
The role of the disulﬁde isomerase proteins DsbC and possibly
DsbG is the isomerization of incorrect disulﬁdes [3,12,13]. These
members of the Dsb family were identiﬁed by two different genetic
approaches [3,13]. DsbC and DsbG share 24% sequence identity with
each other and about 10% sequence identity to thioredoxin [3,14].
DsbC can rearrange disulﬁdes in vitro and in vivo. The addition of
catalytic amounts of DsbC to fully reduced and denatured BPTI in vitro
promotes the formation of correct disulﬁdes in the presence of GSH/
GSSG and leads to active BPTI [15]. In this case glutathione oxidizes
BPTI and potentially incorrect disulﬁdes are isomerized by DsbC. In an
in vivo study BPTI was oxidized in the presence of DsbA, leading to
mispaired disulﬁdes, which were corrected in a DsbC-dependent
manner. This is consistent with the results that we have obtained with
RNaseA. DsbA can oxidize reduced RNaseA to the point that no free
thiols are available, but this does not result in signiﬁcant RNaseA
activity; only upon addition of DsbC is RNaseA activity recovered [16].
We interpreted this to mean that the DsbA oxidizes the protein to
completion but incorporates at least one incorrect disulﬁde, and DsbC
then reshufﬂes the disulﬁdes to the correct conﬁguration. As shown in
Fig. 1 there are several possible mechanisms by which DsbC may
isomerizes incorrect disulﬁde bonds. DsbC attacks incorrect disulﬁdes
forming a mixed disulﬁde between the more N-terminal cysteine of
DsbC and the protein substrate (step 1 in Fig. 1). This disulﬁde may be
immediately transferred back to the protein substrate resulting in a
different and in this case correct disulﬁde bond pattern (step 2 in Fig.
1). This mechanism is called the shufﬂing model for the purposes of
this review. Alternatively the mixed disulﬁde may be resolved suchFig. 1that DsbC is oxidized and the substrate is reduced (step 3 in Fig. 1) The
reduced substratemay then be reoxidized by DsbA or DsbC (step 4 or 5
in Fig. 1). This mechanism is called the reduction/reoxidation model.
This may result in a correct pattern of disulﬁdes. Since correct
disulﬁdes are, in general, stable and buried they will not be attacked
by reduced DsbC so steps 2 and 5 can be considered essentially
irreversible. Incorrect disulﬁdes in contrast are expected to be
exposed and susceptible to attack and will undergo another round
of isomerization. Steps 1, 3 and 4 can be considered to be reversible. It
should be noted that often, particularly in the case where consecutive
disulﬁdes are correct, DsbA will correctly form disulﬁdes in the ﬁrst
place, eliminating the need for isomerization.
Some evidence against the shufﬂing model and in favor of the
reduction/reoxidation mechanism are the observations by Rietsch et
al. [33]. They showed that DsbCmutants that lack themore C-terminal
cysteine are strongly deﬁcient in the expression of urokinase,
implying that they are deﬁcient in isomerization. They also showed
that in a DsbA, DsbD double mutant, DsbC's active site cysteines are in
a reduced state, while in a DsbD mutant DsbC is in the oxidized state.
This seems to indicate that the oxidation of DsbC's active site cysteines
is dependent on DsbA. Since DsbA and DsbC do not directly interact,
the oxidation of DsbC likely takes place through DsbA oxidizing
protein substrates which are then reduced by DsbC, favoring the
reduction/isomerization model.
Compared to PDI, a well-studied eukaryotic isomerase, DsbC is
not as catalytically active, with PDI being 10-fold faster in regard to
the disulﬁde rearrangement in bovine pancreatic trypsin inhibitor
(BPTI) [15]. Compared to DsbA, however, DsbC is much more active
as an isomerase in the in vitro refolding of Ragi bifunctional inhibitor
(RBI), a protein with ﬁve nonconsecutive disulﬁdes. DsbC seems to
be particularly efﬁcient in rearranging buried, nonnative disulﬁdes
that have been formed by treatment of RBI with oxidants such as
GSSG [17].
In vivo DsbC has been shown to increase the yield of overall
correctly disulﬁde bonded E. coli and eukaryotic proteins with non-
consecutive disulﬁde bonds. For example, the formation of active
murine urokinase containing 12 disulﬁdes is decreased 100-fold in a
dsbC− strain compared to the wild-type strain, which indicates that
DsbC is required for the formation of the correct disulﬁde bonds [18].
Joly and Swartz investigated the expression of a variety of eukaryotic
proteins in a dsbC− strain [19]. The inﬂuence of DsbC on the formation
of active eukaryotic proteins strongly depends on the model protein
used, and whether the disulﬁdes are consecutive or nonconsecutive.
For melanoma growth stimulating activity (MGSA) and insulin-like
growth factor 1 (IGF-1), proteins that require nonconsecutive.
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protein. However, human growth hormone (hGH) and anti-CD18
antibody, proteins that contain consecutive disulﬁdes, showed similar
expression levels in a dsbC− and a wild-type strain [19]. The assembly
of pertussis toxin, which requires 11 consecutive disulﬁdes, requires
DsbA but not DsbC [20]. Periplasmic proteins whose disulﬁde bonding
pattern are known to be decreased in amount in dsbC− strains include
RNaseI, and phytase, both of which contain a non-consecutive
disulﬁde [21]. This ability of DsbC to speciﬁcally assist in the
expression of proteins with nonconsecutive disulﬁdes strongly
suggests that DsbC acts as an isomerase.
Perhaps the strongest evidence for a speciﬁc requirement of DsbC
in folding proteins with nonconsecutive disulﬁdes comes from
experiments conducted with phytase. Phytase is an E. coli periplasmic
protein that contains three consecutive disulﬁde bonds and one
nonconsecutive one. Its expression is DsbC-dependent, unless the
nonconsecutive disulﬁde is removed by mutation, when it becomes
DsbC-independent [6]. It has been proposed that DsbA acts immedi-
ately on proteins as they are translocated into the periplasm. Evidence
for this also comes from a mutant in alkaline phosphatase (AP) in
which the most amino-terminal cysteine was replaced with serine.
Alkaline phosphatase normally contains two consecutive disulﬁdes,
one that links the ﬁrst and second cysteines in the protein, and one
that links the third and fourth. Upon removal of the ﬁrst cysteine in AP,
DsbA forms an incorrect disulﬁde. This disulﬁde is slowly resolved in a
DsbC-dependent reaction. Interestingly, more active alkaline phos-
phatase results from expression of this mutant AP in a dsbA null strain
than is formed in a dsbA+ strain. This implies that DsbA may be too
oxidizing for the expression of proteins with nonpaired cysteines [7].
However, a recent report found that RNAseI is oxidized correctly by
DsbA, even though it has a nonconsecutive disulﬁde [44].
The abundance of a number of proteins, including MepA, End1,
YebF, and Ivy, is decreased in the absence of DsbC, suggesting that
these E. coli proteins are in vivo substrates for DsbC [22]. A larger
number of proteins are decreased in amount in dsbA− strains, implying
that DsbA, as the presumptive oxidase, is more important for the
folding of proteins than is DsbC, the presumptive isomerase. Darby et
al. measured the rates at which a 28-mer model peptide reacts with
DsbC and compared it with the rates at which DsbA reacts with the
same peptide. To function as an isomerase, DsbC needs to attack
incorrect disulﬁde bonds. The initial rate at which DsbC reacts with
the model peptide's disulﬁde is about 6×103 more rapid than the
same reaction of the oxidized peptide with reduced DsbA. For
isomerization to occur, a free thiol needs to attack this mixed
disulﬁde, resulting in a different disulﬁde. This reaction occurs 26-
to 43-fold more rapidly with DsbC than it does with DsbA. These
kinetic differences help explain the greater isomerase activity of DsbC
than DsbA [23].
The crystal structure of oxidized DsbC [24] reveals two 23 kDa
monomers of DsbC forming a V shaped homodimer [24]. Each
monomer of DsbC consists of two domains: a C-terminal thior-
edoxin-like domain containing the active site Cys98-Gly-Tyr-Cys102
motif, a structural disulﬁde, and an N-terminal dimerization domain
connected via a ﬂexible linker helix. Mutations that remove the active
site cysteines, as expected, show that they are required for the thiol-
disulﬁde exchange activities of DsbC, but not the chaperone activity.
Mutations that remove the structural disulﬁde increase the sensitivity
of DsbC to denaturants and decrease its folding rate [25]. Dimerization
of DsbC acts to form a large cleft built of uncharged and hydrophobic
residues, whichmay be the binding site for substrate proteins of DsbC.
The active site cysteines of each monomer are oriented facing each
other. The thioredoxin-like domains are separated from the dimeriza-
tion domain by a linker alpha helix. Relative movement of the active
sites and the presumptive peptide binding cleft at the junction of the
arms of the V may be important in DsbC's isomerase or chaperone
activities. It has been suggested that the cleft may act to both bind andpartially shield incompletely folded proteins while the protein
explores various conformations and disulﬁde bonding patterns [24].
DsbC reacts with peptides up to amillion-fold faster than it reacts with
glutathione, and the mixed disulﬁde formed between the peptide and
DsbC is 10,000 times more stable than glutathione-DsbC mixed
disulﬁdes. Noncovalent binding interactions that occur between the
peptide and DsbC likely contribute to these very rapid kinetics of
substrate utilization and the increased stability of the mixed disulﬁde
[23]. In reduced DsbC, the catalytic domains are shifted and twisted up
to 13 Å around an alpha helical hinge located between the catalytic
and dimerization domains. This apparent ﬂexibility of DsbCmay play a
role in accommodating substrates in the cleft between the catalytic
domains.
The function of DsbC as isomerase and chaperone is strictly
dependent on it's dimerization [26]. A screen to ﬁnd mutants of dsbC
that complement a dsbA deﬁciency revealed that mutations in the
dimerization domain of DsbC lead to monomeric DsbC that can act as
an oxidase and, in addition, can interact with DsbB to become
reoxidized [27]. The dimerization of DsbC therefore, is a structural
safeguard against the interactionwith DsbB, protecting the chaperone
and isomerase functions of DsbC. A heterodimer that has had one of
the CXXC active sites inactivated by carboxymethylation has no
isomerase activity [26]. This suggests strongly that both active sites of
the dimer are required for isomerization.
Deletion mutations in the alpha helical linker domain that
connects the dimerization domain to the catalytic domain allow
DsbC to be oxidized by DsbB and also decrease DsbC's isomerization
activity [29,30]. In wild-type DsbC, the active site cysteines are facing
each other; these deletion mutations probably function by rotating
the catalytic domains with respect to each other. The ability of the
mutants to oxidize proteins was inversely related to their ability to
isomerize incorrect disulﬁde bonds. A number of orientations
(including an inward pointing orientation) of the active sites appear
to be associated with high isomerase activity; other orientations leave
DsbC accessible to DsbB, and DsbC thus acquires oxidase activity. All of
the alpha helical linker truncations tested by Segatori et al. are capable
of serving as both an oxidant and an isomerase [29,30]. This mimics
the situation present in eukaryotes, in which protein disulﬁde
isomerase is thought to serve both roles.
Further evidence that the presence of two active sites is important
in facilitating isomerase action is the observation that the addition of
a dimerization domain onto monomeric thioredoxin-like proteins
generates a protein with signiﬁcant isomerase activity in vivo and in
vitro. Dimerization of DsbA, thioredoxin, or monomeric PDI domains
by the fusion of these proteins to the dimerization domain of DsbC
results in a protein that is capable of supporting the formation of
active vtPA in the periplasm and RNaseA in vitro, indicating that
these artiﬁcial dimeric proteins have acquired disulﬁde isomerization
activity [29,30]. Formation of a mixed disulﬁde between these
dimeric disulﬁde isomerases and their substrates will greatly increase
the local concentration of the active sites relative to the substrate. In
contrast, monomeric disulﬁde oxidoreductases like thioredoxin and
DsbA are very inefﬁcient disulﬁde isomerases. This higher isomerase
activity of DsbC compared to DsbA is proposed to be due to a number
of factors in addition to the increased effective concentration of active
sites upon formation of mixed disulﬁdes; these factors include a
higher peptide afﬁnity and a slower and less random oxidation of
substrates by DsbC.
It appears that the equilibrium redox potential alone does not
determine whether a protein primarily functions in the cell as an
oxidase or an isomerase, since DsbC and DsbA both have very similar
and strongly oxidizing redox potentials, and both react very rapidly
with folding proteins and peptides [15]. The ability of mutants in DsbA
to catalyze the folding of multidisulﬁde proteins does not correlate
with their redox potential [31]. To function as an isomerase, DsbC is
kept in the reduced form in vivo by DsbD [18,19,28,32,33]. In contrast,
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state by DsbB. Large kinetic barriers separate the oxidation pathway
from the isomerization pathway. Nonphysiological interactions
between DsbC-DsbB, DsbA-DsbD, and DsbC-DsbA are three to seven
orders of magnitude slower than the physiological interactions [34].
DsbC mutants are copper sensitive. Copper is a redox metal, which
catalyzes disulﬁde bond formation and appears to introduce incorrect
disulﬁdes more frequently than DsbA does. Thus, the copper
sensitivity of dsbC− strains may arise from the inability of the cell to
rearrange copper-catalyzed incorrect disulﬁde bonds. These results
suggest that the primary role of DsbC may be to rearrange incorrect
disulﬁde bonds that are formed during certain forms of oxidative
stress [35]. The structure of DsbC in complex with a fragment of DsbD
revealed that the large cleft can adopt two conformations: an open
and a closed conformation [36]. This ﬂexibility presumably allows
DsbC to adopt the cleft for different substrates. The interface between
the DsbC-DsbD alpha subunit involves only residues from the
thioredoxin domain of DsbC. The contact residues are highly
conserved, which helps explain how a variety of DsbC homologues
isolated from gamma proteobacteria are capable of complementing E.
coli DsbC.
In addition to functioning as an isomerase, DsbC also has
chaperone activity and can assist the refolding of single chain Fv
fragments [37], lysozyme, and glyceraldehyde-3-phosphate-dehydro-
genase (GAPDH). For the latter two proteins, this chaperone activity is
independent of the presence of DsbC's active site cysteines [25]. The
dual mode of action of DsbC is probably the key to its functionality. As
a chaperone, DsbC recognizes misfolded proteins, then the isomerase
function resolves incorrectly formed disulﬁdes. DsbC's ability to bind
to peptides probably contributes to its chaperone activity. A mixed
disulﬁde between a peptide derived from BPTI and DsbC is 100-fold
more stable than between the peptide and DsbA [23].
5. DsbG, a second disulﬁde isomerase?
Although multigene families are less common in prokaryotes than
they are in eukaryotes, they do occasionally occur, the disulﬁde
isomerase family is one example. In general individual members of
multigene families are assumed to have different substrate speciﬁ-
cities, patterns of expression, or localizations. In some cases over-
lapping substrate speciﬁcity and expression patterns may lead to
redundancy. A second putative isomerase in the periplasm of E. coli,
DsbG, was discovered using a DTT based screen and because of its 24%
sequence identity to DsbC [12]. Originally DsbG was described as a
disulﬁde oxidase [12], but it is now thought that DsbG acts as a second
isomerase in the periplasm of E. coli [14]. In vitro, DsbG has chaperone
and isomerase activity [14,38]. Overexpression of DsbG, like DsbC
overexpression, enhances the proper expression of single chain Fv
antibody fragments, and the effect of DsbC and DsbG appears to be
additive. However, DsbG does not catalyze insulin reduction, a
standard thiol-disulﬁde redox reaction, and fails to catalyze the
oxidative refolding of RNaseA [14]. The structures of DsbC and DsbG
closely resemble each other [39]. However, DsbG is signiﬁcantly larger
because the helix that links the dimerization and catalytic domains is
about 2.5 turns longer in DsbG. This acts to substantially increase the
dimensions of the substrate binding cleft. In addition, DsbG possesses
some conserved acidic residues in the generally hydrophobic
substrate binding cleft that are not present in DsbC. These differences
have led to the hypothesis that DsbC and DsbG vary in substrate
speciﬁcity. DsbC is proposed to interact with unfolded hydrophobic
polypeptide chains, whereas DsbG is proposed to interact with larger,
at least partially folded substrates with charged surfaces [39].
Although a number of E. coli substrates are known for DsbC, none
has yet been detected for DsbG. DsbG is normally expressed at lower
levels than is DsbC. Since no protein that is abundant under normal
laboratory growth conditions is present in dramatically reducedconcentrations in DsbG null mutants it seems likely that DsbG is
acting on proteins that are not normally abundant. In vivo, over-
expression of DsbG in dsbC− strains allows the production of
comparable levels of BPTI as in dsbC+ E. coli strains, suggesting that
DsbG also functions in vivo as an isomerase [14]. Mutations in DsbG
have been isolated that allow it to complement the copper sensitivity
of dsbC null strains [40].
That simple overexpression of the isomerases DsbC and DsbG
assists in the folding of a number of eukaryotic proteins indicating that
the periplasm of E. coli can be altered to improve the folding of
eukaryotic disulﬁde containing proteins. Most peptides and proteins
with therapeutic applications contain disulﬁdes. The proper formation
of these disulﬁdes is one of the rate limiting steps in the commercial
production of these proteins. Because the puriﬁcation of the correctly
disulﬁde bonded form of the protein as the active pharmaceutical
ingredient turns out to be very complicated when multiple possibi-
lities of disulﬁde bonding are possible, these therapeutic proteins are
very expensive. Further optimization of the periplasm for thiol-
disulﬁde exchange is clearly of great interest for the commercial
production of disulﬁde containing proteins. It has been observed that
DsbC variants that contain alterations in the dipeptide sequence
between the active site cysteine residues increase the yield of mouse
urokinase up to ﬁve-fold [31]. Further, optimization of the periplasm
for thiol-disulﬁde exchange is clearly of great interest for the
commercial production of disulﬁde containing proteins. Selection for
chromosomal mutations that enhance the folding of tissue plasmino-
gen activator yielded mutants that up-regulate DsbC due to mutations
that result in reduced function of RNaseE. This suggests a critical role
of RnaseE in regulating DsbC expression [41].
6. Comparison between the prokaryotic disulﬁde isomerases DsbC
and DsbG, and eukaryotic PDI
The recently solved crystal structure of eukaryotic PDI reveals a
number of striking similarities to DsbC and DsbG, including domain
arrangement, active site location, and surface features [42]. Interest-
ingly, these structural similarities are in large part due to convergent
evolution. Nevertheless, the overall effect is very similar. Both
prokaryotic and eukaryotic disulﬁde isomerases have a V or U
shape, with two active site CXXC motifs embedded in a thioredoxin-
like fold that face each other across the U. The eukaryotic PDI achieves
this by covalently linking four thioredoxin domains, with the N- and
C-terminal domains possessing the active site CXXCmotifs, which face
each other across the interior of the U; the two internal domains are
catalytically inactive. In contrast, DsbC and DsbG utilize a thioredoxin
unrelated domain to dimerize two monomers, each of which
possesses a single CXXC active site containing a thioredoxin-like
domain. It appears that two thioredoxin-like domains in close spatial
proximity on opposite sides of a large cleft are required for disulﬁde
isomerase activity. Individual catalytic domains of PDI, though redox
active, are essentially inactive as isomerases, and heterodimers of
DsbC in which one active CXXC motif is carboxymethylated are also
inactive as an isomerase in vivo [26]. The two active sites of PDI
presumably act in a concerted fashion on its substrates.
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